These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24786879)

  • 1. Update to hepatitis C review.
    Fabrizi F; Messa P; Martin P
    Kidney Int; 2014 May; 85(5):1238-9. PubMed ID: 24786879
    [No Abstract]   [Full Text] [Related]  

  • 2. What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations.
    Carrion AF; Martin P
    Semin Dial; 2014; 27(5):446-8. PubMed ID: 25204876
    [No Abstract]   [Full Text] [Related]  

  • 3. What are the management issues for hepatitis C in dialysis patients?: epidemiology and prevention of hepatitis C virus transmission in the hemodialysis setting.
    Jadoul M; Fabrizi F
    Semin Dial; 2014; 27(5):449-51. PubMed ID: 25204877
    [No Abstract]   [Full Text] [Related]  

  • 4. Eradicating the Viral Triad in Hemodialysis Units.
    Adams B; Yee J
    Adv Chronic Kidney Dis; 2019 May; 26(3):157-161. PubMed ID: 31202386
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment.
    Dzekova-Vidimliski P; Sikole A
    Int J Artif Organs; 2017 Feb; 39(12):590-595. PubMed ID: 28165585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C treatment in patients with kidney disease.
    Fabrizi F; Aghemo A; Messa P
    Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should all dialysis patients with hepatitis C be treated? If so, before or after kidney transplantation?
    Jadoul M; Martin P
    Semin Dial; 2017 Sep; 30(5):395-397. PubMed ID: 28786139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infection.
    Tavares RCF; Feldner ACCA; Pinho JRR; Uehara SNO; Emori CT; Carvalho-Filho RJ; Silva ISS; Santana RAF; de Castro VFD; Castoli GTF; Cristovão CU; Ferraz MLCG
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):754-758. PubMed ID: 28234637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caution with the use of the new direct acting antivirals in the hepatitis C virus related renal disease.
    Gomis A; Díaz M; de Lorenzo A; Ruiz-Roso G; Liaño F
    Nefrologia; 2016; 36(6):713-715. PubMed ID: 27575928
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon therapy of acute hepatitis C in dialysis patients: meta-analysis.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2012 Nov; 19(11):784-91. PubMed ID: 23043385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis C virus infection in dialysis patients: does it need special attention?
    Rezaee-Zavareh MS; Ramezani-Binabaj M; Einollahi B
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):368-9. PubMed ID: 25758893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sofosbuvir and daclatasvir combination therapy in hemodialysis patient with liver transplantation].
    Hachicha M; Botta-Fridlund D
    Nephrol Ther; 2016 Dec; 12(7):536-538. PubMed ID: 27825643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are HVC patients on hemodialysis really difficult to treat patients?].
    Krati K; Cherquaoui H; Oubaha S; Samlani Z
    Pan Afr Med J; 2015; 22():373. PubMed ID: 27022433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming a treatment barrier in treating hepatitis C in dialysis patients.
    Lapumnuaypol K; Feyssa E
    Semin Dial; 2018 Mar; 31(2):193. PubMed ID: 29405426
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C Virus Infection in Kidney Transplant Patients: Current Treatment Options.
    Dzekova-Vidimliski P; Sikole A
    Exp Clin Transplant; 2017 Dec; 15(6):587-593. PubMed ID: 29219790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C in Patients With RenalDisease: A Deeper Dive Into the KDIGO Guideline.
    Terrault NA
    Hepatology; 2018 Nov; 68(5):2035-2038. PubMed ID: 29672896
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 19. Pegylated interferon for the treatment of hepatitis C virus in haemodialysis patients.
    Teta D; Lüscher BL; Gonvers JJ; Francioli P; Phan O; Burnier M
    Nephrol Dial Transplant; 2005 May; 20(5):991-3. PubMed ID: 15741205
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney disease.
    Maruyama A; Partovi N; Yoshida EM; Erb SR; Azalgara VM; Hussaini T
    Nephrol Dial Transplant; 2017 Jan; 32(1):35-41. PubMed ID: 26481484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.